Clinical Trials Logo

Clinical Trial Summary

Proliferative diabetic retinopathy (PDR) is treated with conventional pan retinal photocoagulation (PRP) which can improve the visual prognosis in this complication significantly. However , the treatment may also resulting adverse effects such as blurring of central vision, visual field constriction and disturbance in dark adaptation and contrast vision. Extended targeted retinal coagulation (TRP) to the ischemic areas may cause regression of the neovascularization while minimizing some of the risks and complication associated of treatment of PDR with these two methods.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01232179
Study type Interventional
Source hahid Beheshti University of Medical Sciences
Contact
Status Recruiting
Phase Phase 2
Start date October 2010
Completion date May 2011